Case Report
Published on 01 Nov 2024
Case Report: Dual monoclonal antibody therapy in chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma—a proteome analysis
Frontiers in Allergy
doi 10.3389/falgy.2024.1484931
- 107 views
Volumes
545 Publications
Volume 5 - 2024
Hypothesis and Theory
Published on 01 Nov 2024
The Acari Hypothesis, V: deciphering allergenicity
Frontiers in Allergy
doi 10.3389/falgy.2024.1454292
- 384 views
Case Report
Published on 01 Nov 2024
Case Report: Anaphylaxis caused by traditional Chinese medicine in a patient with pollinosis
Frontiers in Allergy
doi 10.3389/falgy.2024.1470638
Systematic Review
Accepted on 31 Oct 2024
Baricitinib as Monotherapy and with Topical Corticosteroids in Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Dose-Response
Frontiers in Allergy
doi 10.3389/falgy.2024.1486271
Original Research
Accepted on 30 Oct 2024
Common pollen and related allergen components in patients with allergic diseases in the Beijing area
Frontiers in Allergy
doi 10.3389/falgy.2024.1478392
Perspective
Accepted on 30 Oct 2024
Thymus and Activation-regulated Chemokine (CCL17) As a Clinical Biomarker in Atopic Dermatitis: Significance and Limitations in the New Treatment Era
Frontiers in Allergy
doi 10.3389/falgy.2024.1473902
Original Research
Accepted on 30 Oct 2024
Pediatric eosinophilic esophagitis: A Belgian single-center retrospective analysis reveals real-life difficulties in diagnosis and treatment
Frontiers in Allergy
doi 10.3389/falgy.2024.1478380
Original Research
Accepted on 30 Oct 2024
Assessing the predictive potential of ADAM8 for disease control in chronic rhinosinusitis with nasal polyps
Frontiers in Allergy
doi 10.3389/falgy.2024.1488441
Brief Research Report
Accepted on 28 Oct 2024
Clinical and Sensitization Profile in Peach Allergy due to LTP Sensitization
Frontiers in Allergy
doi 10.3389/falgy.2024.1477364
Review
Accepted on 28 Oct 2024
Phototherapy as an alternative in the treatment of chronic spontaneous urticaria
Frontiers in Allergy
doi 10.3389/falgy.2024.1468983
Editorial
Published on 25 Oct 2024
Editorial: In vitro diagnosis of allergic and mast cell-mediated disorders
Frontiers in Allergy
doi 10.3389/falgy.2024.1483398
- 314 views
Original Research
Published on 25 Oct 2024
Patient autonomy in self-managing their bronchial asthma exacerbation and its associated factors, 2024
Frontiers in Allergy
doi 10.3389/falgy.2024.1483897
- 290 views
Original Research
Published on 25 Oct 2024
Altered expression of long noncoding RNAs regulating neutrophilic inflammation in peripheral blood was associated with symptom severity in patients with house dust mite-induced allergic rhinitis
Frontiers in Allergy
doi 10.3389/falgy.2024.1466480
- 218 views
Mini Review
Published on 25 Oct 2024
Experimental models of antibiotic exposure and atopic disease
Frontiers in Allergy
doi 10.3389/falgy.2024.1455438
- 140 views
Case Report
Accepted on 23 Oct 2024
Angiotensin Converting Enzyme Inhibitors (ACE-Is) versus Angiotensin Receptor Blockers (ARBs) in the Management of Chronic Hypertension: A Case of Lisinopril-Induced Rhinorrhea
Frontiers in Allergy
doi 10.3389/falgy.2024.1480569
Original Research
Accepted on 23 Oct 2024
Spectrum of offending drugs and cutaneous adverse drug reactions requiring hospitalisation in a tertiary South African hospital in TB/HIV endemic setting
Frontiers in Allergy
doi 10.3389/falgy.2024.1481281